Unibest

Pharmaceutical intermediates

Brivaracetam Intermediates

2 pharmaceutical intermediates for Brivaracetam. Indication: Epilepsies, Partial; Epilepsies; Seizures.

Submit a ProjectAll intermediates

About Brivaracetam

Originator
Ucb Inc.
Indication
Epilepsies, Partial; Epilepsies; Seizures
Approved Date
05/12/2016
DS/DP
02/21/2026

Available intermediates

2 intermediates currently listed for Brivaracetam. Request specifications, documentation or a quotation for any item below.

Brivaracetam intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
Brivaracetam357336-20-0//
(+)-(R)-4-propyl-4,5-dihydrofuran-2(3H)-one63095-51-2//

Other programs under B

Baloxavir MarboxilBaricitinibBDTX-1535Bedaquiline FumarateBelumosudil mesylateBelzutifanBempedoic acidBeraprost Sodium

Building toward Brivaracetam?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →